These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28611130)

  • 1. Precision Medicine for Heart Failure: Lessons From Oncology.
    Feldman AM; Kontos CD; McClung JM; Gerhard GS; Khalili K; Cheung JY
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611130
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of soluble BAG3 and anti-BAG3 antibodies in patients with chronic heart failure.
    De Marco M; Falco A; Basile A; Rosati A; Festa M; d'Avenia M; Pascale M; Dal Piaz F; Bisogni R; Barcaroli D; Coppola G; Piscione F; Gigantino A; Citro R; De Rosa R; Vitulano G; Virtuoso N; Manganelli F; Palermo E; Siano F; Rosato G; Hahne M; Tiberti C; De Laurenzi V; Turco MC
    Cell Death Dis; 2013 Feb; 4(2):e495. PubMed ID: 23412388
    [No Abstract]   [Full Text] [Related]  

  • 3. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
    Fiore RN; Goodman KW
    Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.
    Saulsberry L; Olopade OI
    Cancer Cell; 2021 Jun; 39(6):730-733. PubMed ID: 34019805
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of CARMA1/BCL10/MALT1 expression in Reed-Sternberg cells of classical Hodgkin lymphoma.
    Re D; Hartlapp I; Greiner A; Diehl V; Wickenhauser C
    Leuk Lymphoma; 2008 Feb; 49(2):362-4. PubMed ID: 18231929
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.
    Cresci S; Pereira NL; Ahmad F; Byku M; de Las Fuentes L; Lanfear DE; Reilly CM; Owens AT; Wolf MJ
    Circ Genom Precis Med; 2019 Oct; 12(10):458-485. PubMed ID: 31510778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is cardio-oncology a rapidly growing field of precision medicine?
    Farmakis D
    Eur J Heart Fail; 2020 Dec; 22(12):2310-2313. PubMed ID: 33175447
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality in the Age of Precision Medicine: The Clinician Perspective.
    Romine PE; Harkins SK; Gray SW
    J Oncol Pract; 2016 Oct; 12(10):839-843. PubMed ID: 27650835
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Jordà P; Martínez D; Farrero M; Marcos MÁ; Sandoval E; Castel MÁ; Pereda D; Quintana E; Arbelo E; Sánchez A; Campuzano Ò; Tirón de Llano C; Brugada R; Brugada J; Castellá M; Pérez-Villa F; García-Álvarez A
    Circ Heart Fail; 2022 Mar; 15(3):e008443. PubMed ID: 35290091
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspective on precision medicine in paediatric heart failure.
    Fridman MD; Mital S
    Clin Sci (Lond); 2017 Mar; 131(6):439-448. PubMed ID: 28265035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big science has a buzzword problem.
    Scudellari M
    Nature; 2017 Jan; 541(7638):450-453. PubMed ID: 28128261
    [No Abstract]   [Full Text] [Related]  

  • 12. Precision Oncology in Canada: Converting Vision to Reality with Lessons from International Programs.
    Liu G; Cheung WY; Feilotter H; Manthorne J; Stockley T; Yeung M; Renouf DJ
    Curr Oncol; 2022 Sep; 29(10):7257-7271. PubMed ID: 36290849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision and predictive medicine: lessons learned from our oncology colleagues.
    O'Connor CM
    JACC Heart Fail; 2014 Dec; 2(6):671. PubMed ID: 25468289
    [No Abstract]   [Full Text] [Related]  

  • 14. Precision medicine for heart failure based on molecular mechanisms: The 2019 ISHR Research Achievement Award Lecture.
    Nomura S; Komuro I
    J Mol Cell Cardiol; 2021 Mar; 152():29-39. PubMed ID: 33275937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Medicine in Oncology II: Economics of Targeted Agents and Immuno-Oncology Drugs.
    Huntington SF; Davidoff AJ; Gross CP
    J Clin Oncol; 2020 Feb; 38(4):351-358. PubMed ID: 31804866
    [No Abstract]   [Full Text] [Related]  

  • 16. Deciphering expression and variants in cardiovascular disease genes among heart failure population for precision medicine.
    Ahmed Z
    ESC Heart Fail; 2024 Feb; 11(1):606-609. PubMed ID: 38131165
    [No Abstract]   [Full Text] [Related]  

  • 17. Induced Pluripotent Stem Cell (iPSC)-Derived Exosomes for Precision Medicine in Heart Failure.
    Yang PC
    Circ Res; 2018 Mar; 122(5):661-663. PubMed ID: 29496797
    [No Abstract]   [Full Text] [Related]  

  • 18. Precision Medicine and the Changing Landscape of Research Ethics.
    Hammer MJ
    Oncol Nurs Forum; 2016 Mar; 43(2):149-50. PubMed ID: 26906126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of nonresponders to cardiac resynchronization therapy: lessons learned from oncology.
    Ruschitzka F
    Heart Rhythm; 2012 Aug; 9(8 Suppl):S14-7. PubMed ID: 22521933
    [No Abstract]   [Full Text] [Related]  

  • 20. Variations on a Precision Medicine Theme: One Size Fits Some.
    Hauptman PJ; Gong TA; Vidic A
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27470498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.